328 related articles for article (PubMed ID: 23663760)
1. [Antiviral activities of ISG20 against hepatitis C virus].
Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760
[TBL] [Abstract][Full Text] [Related]
2. [Construction and functional characterization of a monocistronic replicon based on the HCV genotype 2a promotor].
Li XL; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):103-7. PubMed ID: 22464780
[TBL] [Abstract][Full Text] [Related]
3. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
Ikeda M; Yi M; Li K; Lemon SM
J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
[TBL] [Abstract][Full Text] [Related]
4. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
5. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
6. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.
Jiang D; Guo H; Xu C; Chang J; Gu B; Wang L; Block TM; Guo JT
J Virol; 2008 Feb; 82(4):1665-78. PubMed ID: 18077728
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a full-genome HCV replicon with self-cleaving double ribozyme sequences and characterization in vitro and in vivo].
He CL; Liu QS; Guo Y; Zhu Y; Mao Q; Lan L
Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):348-53. PubMed ID: 24025135
[TBL] [Abstract][Full Text] [Related]
8. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon.
Targett-Adams P; McLauchlan J
J Gen Virol; 2005 Nov; 86(Pt 11):3075-3080. PubMed ID: 16227230
[TBL] [Abstract][Full Text] [Related]
10. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
[TBL] [Abstract][Full Text] [Related]
11. Active RNA replication of hepatitis C virus downregulates CD81 expression.
Ke PY; Chen SS
PLoS One; 2013; 8(1):e54866. PubMed ID: 23349980
[TBL] [Abstract][Full Text] [Related]
12. Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells.
Murray EM; Grobler JA; Markel EJ; Pagnoni MF; Paonessa G; Simon AJ; Flores OA
J Virol; 2003 Mar; 77(5):2928-35. PubMed ID: 12584317
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
[TBL] [Abstract][Full Text] [Related]
14. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
[TBL] [Abstract][Full Text] [Related]
15. Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).
Miyamoto M; Kato T; Date T; Mizokami M; Wakita T
Intervirology; 2006; 49(1-2):37-43. PubMed ID: 16166787
[TBL] [Abstract][Full Text] [Related]
16. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
[TBL] [Abstract][Full Text] [Related]
17. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.
Kato T; Date T; Miyamoto M; Furusaka A; Tokushige K; Mizokami M; Wakita T
Gastroenterology; 2003 Dec; 125(6):1808-17. PubMed ID: 14724833
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
[TBL] [Abstract][Full Text] [Related]
19. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
[TBL] [Abstract][Full Text] [Related]
20. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
